Bytes to Blood-Artificial Intelligence in the Management of Leukemia: A 2025 Update [0.03%]
从字节到血液：人工智能在白血病管理中的应用（2025年更新）
Austin P Runde,Stephanie M Koo,Parnaz Daneshpajouhnejad et al.
Austin P Runde et al.
As artificial intelligence (AI) has been proposed to aid in the clinical management of leukemia, we sought to summarize the most relevant, current literature concerning this topic. PubMed was indexed from January 2022 to November 2025 using...
Disparities in the Receipt of Palliative-Intent Treatment Among Disaggregated Hispanic Populations With Stage IV Liver Cancer in the United States [0.03%]
美国晚期肝癌患者中不同西班牙裔人群接受姑息治疗的差异性分析
Shriya K Garg,Perisa Ashar,Khushi Kohli et al.
Shriya K Garg et al.
Objectives: Our study investigates disparities in receipt of palliative-intent care among broad racial/ethnic and disaggregated Hispanic subgroups with stage IV liver cancer. ...
Rising Pancreatic Adenocarcinoma and Type 2 Diabetes Mellitus-Related Mortality in the United States, 2000 to 2024, With Forecasts to 2034 [0.03%]
美国2000年至2024年胰腺腺癌和2型糖尿病相关死亡率上升，预测至2034年
Arkadeep Dhali,Rick Maity,Abdul R Faisal et al.
Arkadeep Dhali et al.
Objective: This study analyzed mortality trends for pancreatic adenocarcinoma among individuals with type 2 diabetes mellitus (T2DM) in the United States from 2000 to 2024 and forecasted the future burden. ...
A Phase 1 Study of Neoadjuvant Cabozantinib in Combination With Radiation Therapy for Sarcomas of the Extremities [0.03%]
卡博替尼联合放疗新辅助治疗四肢肉瘤的Ⅰ期研究
Hannah R Abrams,Elizabeth T Loggers,Michael J Wagner et al.
Hannah R Abrams et al.
Objectives: Cabozantinib demonstrates activity in multiple soft tissue sarcoma (STS) subtypes, but use with concurrent radiation therapy (RT) has been limited by concern for risk of fistula or perforation. This phase 1 tr...
Trends in Neoadjuvant Pembrolizumab Use in Triple-Negative Breast Cancer [0.03%]
新辅助派姆单抗在三阴性乳腺癌中的应用趋势
Ellen Li,Samantha R Spierling Bagsic,Rebecca F Belasco et al.
Ellen Li et al.
Objective: The addition of pembrolizumab to neoadjuvant chemotherapy (NAC) has improved treatment efficacy in triple-negative breast cancer (TNBC). The objective of this research was to investigate the national rates of N...
The Landscape of Clinical Trials for Claudin18.2-Positive Gastric Cancer [0.03%]
Claudin18.2阳性胃癌的临床试验现状与挑战
Xingcan Fan,Wen Zhang,Qiuyu Liao et al.
Xingcan Fan et al.
Objectives: Gastric cancer continues to pose a notable global health challenge, with advanced-stage disease carrying a guarded prognosis. Claudin-18.2 (CLDN18.2), as a member of the Claudin protein family, plays a crucial...
Variation in Practice Patterns Among Radiation Oncologists Treating Oropharyngeal Cancers [0.03%]
放射肿瘤学专家治疗口咽癌的实践模式差异
Morgan Bailey,Jonathan Sackett,Hope Esslinger et al.
Morgan Bailey et al.
Objectives: Given the favorable prognosis of HPV-mediated (HPV+) oropharyngeal (OPX) cancers, studies have attempted to de-escalate therapy. We surveyed expert head and neck (H&N) radiation oncologists to better understan...
Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma [0.03%]
美国镭学会（ARS）胃腺癌局部区域适当应用标准（AUC）执行摘要
Leila Tchelebi,Zhaohui Jin,Joseph Attallah et al.
Leila Tchelebi et al.
Objectives: To summarize recent high-quality trials and provide an update to the original 2022 American College of Radiology Appropriate Use Criteria for Treatment of Locoregional Gastric Adenocarcinoma. This multi-specia...
Relevance of Chemokines in Mobilizing γδ T Cells in the Biliary Tract Cancer Microenvironment: Potential for γδ T-Cell-Based Adoptive Cell Therapy [0.03%]
细胞趋化因子在胆道癌微环境中动员γδT细胞的相关性：基于γδT细胞的过继性细胞治疗的潜在作用
Saikat Mandal,Arkadeep Dhali,Manideepa Maji et al.
Saikat Mandal et al.
Objective: Biliary tract cancer (BTC) has a poor prognosis with limited therapeutic options. γδ T cells represent an MHC-independent immune cell population; however, their therapeutic efficacy in solid tumors is constra...
Surveillance Strategies in Follicular Non-Hodgkin's Lymphoma's Using Molecular and Genetic Markers Improve Cost-efficiencies Over Routine Imaging Studies [0.03%]
采用分子及遗传标记监测滤泡性非霍奇金淋巴瘤的策略相较于常规影像学检查具有更高的成本效益
Cherian Verghese,Kapil Meleveedu,Urja Nagadia et al.
Cherian Verghese et al.
Follicular lymphoma is the most common indolent non-Hodgkin's lymphoma subtype. Newer therapies have improved outcomes leading to longer survival in 80% of follicular lymphomas. Only 20% patients have either early relapses or undergo transf...